Abstract
Lung cancer has been the most common cancer in the world for several decades.
As majority of the patients of non-small cell lung cancer present in locally advanced stage along with poor general condition, therefore they cannot tolerate conventional radical regimes and doses of radiotherapy and chemotherapy. Such patients require urgent symptomatic relief and reduction in tumor burden. Therefore for such patients an individualized treatment approach has to be crafted. We are reporting a case of locally advanced non-small cell lung cancer which showed a miraculous response to an individualized approach of sequential therapy comprising of Radiotherapy, chemotherapy and metronomic Cyclophosphamide.
References
- Prasad R, Singhal S, Garg R. Bidi smoking and lung cancer. Biosci Trends. 2009 Apr;3(2):41-3.
- Ferlay J, Soeriomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2018 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France International Agency for Research on Cancer; 2018.
- Indian Council of Medical research; 2013. [accessed on June, 2016]. National Cancer Registry Programme. Three year report of population based cancer registries: 2009-2011. Available from: http://www.nrcpindia.org
- Pearson FG. Current status of surgical resection for lung cancer. Chest 1997;106:337.
- Zimmermann FB, Bamberg M, Molls M, Jeremic B. Radiation therapy alone in earlystage non-small cell lung cancer. Semin Surg Oncol. 2003;21(2):91-7. Review.
- Sigel K, Lurslurchachai L, Bonomi M, Mhango G, Bergamo C, Kale M, et al. Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer. Lung Cancer. 2013 Nov;82(2):266-70.
- Nieder C, Tollali T, Yobuta R, Reigstad A, Flatoy LR, Pawinski A. Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Impact of Total Radiation Dose on Survival? J Clin Med Res. 2017 Jun;9(6):482-487.
- Fojo T, Grady C. How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. J Natl Cancer Inst. 2009 Aug 5;101(15):1044-8.
- Kelly M, O'Brien KM, Lucey M, Clough-Gorr K, Hannigan A. Indicators for early assessment of palliative care in lung cancer patients: a population study usinglinked health data. BMC Palliat Care. 2018 Feb 26;17(1):37.
- Tannock IF. Treatment of cancer with radiation and drugs. J ClinOncol. 1996;52:3156- 74
- Vokes, Everett E. Combined modality therapy of solid tumours. Lancet. 1997;349(2 Suppl):4-6.
- Paik PK, Varghese AM, Sima CS, Moreira AL, Ladanyi M, Kris MG, et al. Response to erlotinib in patients with EGFR mutant advanced non-small cell lung cancers with a squamous or squamous-like component. Mol Cancer Ther. 2012;11:2535-40.
- Montagna E, Cancello G, Dellapasque S, et al. Metronomic therapy and Breast cancer: a systemic review. Cancer Treat Rev 2014;40:942-50.
- Miller KD, Sweeney CJ, Sledge GW Jr. Redefining the target: chemotherapeutics as antiangiogenics. J ClinOncol. 2001 Feb 15;19(4):1195-206.
- André N, Banavali S, Snihur Y, Pasquier E. Has the time come for metronomics in low-income and middle-income countries? Lancet Oncol. 2013 May;14(6):e239-48.
- Watanabe Y, Ogo E, Kaida H, Suzuki G, Eto H, Suefuji H, et al. Treatment with low-dose cyclophosphamide and radiation therapy for advanced non-small lung cancer in elderly patient. GanTo Kagaku Ryoho. 2011 Sep;38(9):1503-5.
Corresponding Author
Dr Joydeep Singh Vasant
3rd year post graduate student, Department of Radiotherapy, PGIMS, Rohtak, India
DOI: https://dx.doi.org/10.18535/jmscr/v7i1.26
